Bacteriophage Therapy Market Set to Surge Amid Rising Antibiotic Resistance
The Global Bacteriophage Therapy Market is estimated to be valued at USD 1,377.6 Mn in 2025 and is expected to exhibit a CAGR of 3.7% over the forecast period 2025 to 2032.
Bacteriophage therapy harnesses naturally occurring ****es that specifically infect and destroy bacterial pathogens, offering an innovative alternative to traditional antibiotics. These phage-based products can be formulated as single-strain therapies or complex phage cocktails, providing targeted antimicrobial action while preserving beneficial microbiota and minimizing collateral damage. The advantages of phage therapy include rapid bacterial clearance, reduced risk of resistance development, and customizable treatment profiles, making it particularly valuable against multi****-resistant infections.
Get more insights on, Bacteriophage Therapy Market- https://www.patreon.com/posts/....bacteriophage-129520
#coherentmarketinsights #bacteriophagetherapy #bacteriophagetherapymarket #bacteriophagetherapymarketinsights #escherichiacoli
